The Times Australia
News From Asia

.
Men's Weekly

.

Merck Announces Emerging Biotech Grant Program Winners

  • Award recipients to receive in-kind technologies and services to accelerate therapeutics to market
  • Merck experts to provide consultation and training in qualification, risk assessment, and process optimization
  • Program extended this year to Australia, New Zealand, Taiwan, South Korea

SINGAPORE - Media OutReach Newswire - 1 November 2024 - Merck, a leading science and technology company, today announced the winners of its Emerging Biotech (EB) Grant Program in Asia Pacific.

The Award is designed to support biotech startups with resources to enable emerging companies to discover, develop, optimize, and commercialize therapeutics faster and more efficiently.

Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.



"Merck is committed to supporting exceptional biotech companies to both kickstart and streamline their journey from discovery to manufacturing with our grant program," said Chua Keng Hock, Senior Vice President, Process Solutions Asia Pacific, Life Science business of Merck. "We recognize the complexities involved in delivering next-generation therapies to the market. Merck's EB Grant is designed to expedite the development of treatments that address critical unmet medical needs."

The award recipients are:

Country
Grand Prize Winner
Finalist Prize Winners
Special Mention
Australia & New Zealand
Southern RNA for enabling the manufacturing of mRNA for personalized medicines
Institute for Drug Technology for enabling the manufacturing of antibody-drug conjugates.

Psaio for developing bispecific antibodies targeting prostate-specific antigen to treat prostate cancer.
Kimer Med for developing

a family of broad-spectrum antiviral biologics to treat infectious diseases, and for pandemic protection.
Taiwan
HanchorBio for developing clinical-stage and next-generation immuno-oncology therapies through innovation in cutting-edge designer biologics with novel, multi-functional modalities.
Pell Biomed Technology for developing more efficient and cost-effective gene-modified cell therapies.

Glyconex for glycan-directed cancer therapies including antibody-drug conjugates to treat a range of solid tumors such as gastrointestinal cancers.
Shine-On BioMedical for developing targeted exosomes as a platform for drug delivery as well as tri-specific antibody for cancer treatment.

Merck experts selected the winning submissions based on the scientific and societal merit of the therapy in development and process challenges and expertise gaps that may impact ongoing development. In-kind technologies and services from Merck will be awarded to the winners in Australia & New Zealand and Taiwan to help solve these challenges.

Merck first started the EB grant program in 2014 in the United States and has expanded its reach to include Europe, China, South Korea and Taiwan in recent years. In 2024, the EB Grant was extended to Australia & New Zealand and is open to Taiwan and South Korea (the winners for South Korea were announced in July 2024). To-date, Merck's EB Grant program has awarded technologies and consultation to over 40 biotechnology companies around the world, supporting their efforts to improve patient outcomes for various diseases such as cancer, brain tumors, osteoarthritis, and cardiovascular disorders.

https://www.sigmaaldrich.com/SG/en/applications/pharmaceutical-and-biopharmaceutical-manufacturing/biotech-resource-hub/startup-programs#our-grant-programs

Other Merck grants at group level:
https://www.merckgroup.com/en/research/open-innovation.html

Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

Times Magazine

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Science Behind Reverse Osmosis and Why It Matters

What is reverse osmosis? Reverse osmosis (RO) is a water purification process that removes contaminants by forcing water through a semi-permeable membrane. This membrane allows only water molecules to pass through while blocking impurities such as...

Foodbank Queensland celebrates local hero for National Volunteer Week

Stephen Carey is a bit bananas.   He splits his time between his insurance broker business, caring for his young family, and volunteering for Foodbank Queensland one day a week. He’s even run the Bridge to Brisbane in a banana suit to raise mon...

Senior of the Year Nominations Open

The Allan Labor Government is encouraging all Victorians to recognise the valuable contributions of older members of our community by nominating them for the 2025 Victorian Senior of the Year Awards.  Minister for Ageing Ingrid Stitt today annou...

CNC Machining Meets Stage Design - Black Swan State Theatre Company & Tommotek

When artistry meets precision engineering, incredible things happen. That’s exactly what unfolded when Tommotek worked alongside the Black Swan State Theatre Company on several of their innovative stage productions. With tight deadlines and intrica...

Uniden Baby Video Monitor Review

Uniden has released another award-winning product as part of their ‘Baby Watch’ series. The BW4501 Baby Monitor is an easy to use camera for keeping eyes and ears on your little one. The camera is easy to set up and can be mounted to the wall or a...

The Times Features

Running Across Australia: What Really Holds the Body Together?

How William Goodge’s 3,800km run reveals the connection between movement, mindset, and mental resilience As a business owner, I’ve come to realise that the biggest wins rarely com...

Telehealth is Transforming Healthcare Services in Australia

It has traditionally not been easy to access timely healthcare in Australia, particularly for people who live in remote areas. Many of them spend hours on the road just to see a...

Launchd Acquires Huume, Strengthening Creative Firepower Across Talent-Led Marketing

Launchd, a leader in talent, technology and brand partnerships, has announced its acquisition of influencer talent management agency Huume from IZEA. The move comes as the medi...

Vietnam's "Gold Coast" Emerges as Extraordinary Investment Frontier and Australian Inspired Way of Life

$2 Billion super-city in Vung Tau set to replicate Australia's Gold Coast success story A culturally metamorphic development aptly named "Gold Coast" is set to reshape Vietna...

Choosing the Wrong Agent Is the #1 Regret Among Aussie Property Sellers

Selling your home is often one of the largest financial transactions you’ll make, and for many Australians, it’s also one of the most emotional. A new survey of Australian home se...

Travel Insurance for Families: What Does it Cover and Why it’s Essential

Planning a family trip is exciting, but unexpected mishaps can turn your dream vacation into a stressful ordeal. That’s where travel insurance comes in—it’s your safety net when ...